Soleno Therapeutics, Inc. (SLNO)
NCM – Real vaqt narxi. Valyuta: USD
53.01
+53.01 (0.00%)
Yopilishda: May 15, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
53.01
+53.01 (0.00%)
Yopilishda: May 15, 2026, 4:00 PM EDT
Soleno Therapeutics, Inc., biofarmatsevtik kompaniya, kam uchraydigan kasalliklarni davolash uchun yangi terapevtik vositalarni ishlab chiqish va tijoratlashtirishga qaratilgan. Uning asosiy dori nomzodi VYKAT XR bo'lib, Prader-Willi sindromini davolash uchun uzaytirilgan chiqariladigan tabletkalardir. Kompaniya ilgari Capnia, Inc. nomi bilan tanilgan va 2017 yil may oyida Soleno Therapeutics, Inc. nomini o'zgartirgan. Soleno Therapeutics, Inc. 1999 yilda tashkil etilgan va Redvud-Siti, Kaliforniyada joylashgan. 18-may, 2026-yil holatiga ko'ra, Soleno Therapeutics, Inc. Neurocrine Biosciences, Inc. kompaniyasining sho'ba korxonasi sifatida faoliyat yuritadi.
| Ism | Lavozim |
|---|---|
| Dr. Anish Bhatnagar M.D. | Chairman, President & CEO |
| Dr. Manher A. Joshi M.D. | Chief Development Officer |
| Dr. Neil M. Cowen M.B.A., Ph.D. | Senior Vice President of New Product Planning |
| Mr. James H. MacKaness | Executive Officer |
| Mr. Jesse Schumaker | General Counsel |
| Mr. Kevin Norrett M.B.A., M.S. | Chief Business Officer |
| Ms. Jennifer Fulk | Chief Financial Officer |
| Ms. Kristen Yen M.S. | Senior Vice President of Global Clinical Operations and Patient Advocacy |
| Ms. Lauren Budesheim | Senior Vice President of People |
| Ms. Meredith Manning M.B.A. | Chief Commercial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-18 | POSASR | d109157dposasr.htm |
| 2026-05-07 | 10-Q | slno-20260331.htm |
| 2026-04-30 | 10-K/A | slno-20251231.htm |
| 2026-04-28 | SC 14D9/A | d149346dsc14d9a.htm |
| 2026-04-20 | SC TO-T | d140647dsctot.htm |
| 2026-04-07 | SC TO-C | d91998dsctoc.htm |
| 2026-04-07 | 8-K | d141594d8k.htm |
| 2026-04-06 | SC14D9C | d111234dsc14d9c.htm |
| 2026-04-06 | 8-K | d142985d8k.htm |
| 2026-03-16 | 8-K | d107502d8k.htm |